B Barbieri

Summary

Country: Sweden

Publications

  1. ncbi Coenzyme Q10 administration increases antibody titer in hepatitis B vaccinated volunteers--a single blind placebo-controlled and randomized clinical study
    B Barbieri
    Vitamex AB, Norrkoping, Sweden
    Biofactors 9:351-7. 1999
  2. ncbi p-Aminobenzoic acid and its metabolite p-acetamidobenzoic acid inhibit agonist-induced aggregation and arachidonic acid-induced [Ca2+]i transients in human platelets
    B Barbieri
    Vitamex Numico, Norrkoping, Sweden
    Thromb Res 95:235-43. 1999

Detail Information

Publications2

  1. ncbi Coenzyme Q10 administration increases antibody titer in hepatitis B vaccinated volunteers--a single blind placebo-controlled and randomized clinical study
    B Barbieri
    Vitamex AB, Norrkoping, Sweden
    Biofactors 9:351-7. 1999
    ..Statistics revealed that Q10 in the dose 180 mg/day is able to increase antibody response in vivo in humans vaccinated against hepatitis B with up to 57% (p = 0.011)...
  2. ncbi p-Aminobenzoic acid and its metabolite p-acetamidobenzoic acid inhibit agonist-induced aggregation and arachidonic acid-induced [Ca2+]i transients in human platelets
    B Barbieri
    Vitamex Numico, Norrkoping, Sweden
    Thromb Res 95:235-43. 1999
    ..However, we have found that PABA and PACBA inhibit the intracellular aequorin indicated Ca2+ transient upon arachidonic acid stimulation. Our results describe a hitherto unknown effect of PABA and PACBA on platelet aggregation...